Healthcare delivery faces the multiple challenges of limited resources, increasing expenditures, increasing expectations, greater complexity, costly new technology, and limited healthcare access. As pharmaceutical policy issues become larger and more complex, the need for professionally trained translational pharmaceutical research scientists to analyze medication outcomes and policy planning has never been greater.
The POP program's training will focus on the relationship between pharmacotherapy and health outcomes, pharmacoepidemiology, informatics, and pharmaceutical policy. The program will prepare students for careers in the pharmaceutical industry, managed care companies, governmental positions related to healthcare benefits, and academic positions focused on research related to pharmaceutical outcomes and policy. The program core is composed of courses in epidemiology, policy, and statistics relevant to the field of POP.
Institute of Pharmaceutical Outcomes & Policy
Our faculty have expertise in methods related to:
Our faculty conduct research in areas related to:
Prospective Students
Prospective graduate students come from a pool of applicants with backgrounds in pharmacy and other fields such as anthropology, biology, business administration, dentistry, economics, epidemiology, gerontology, health administration, medicine, nursing, public health, political science, psychology, public administration, public policy, social work, sociology, and others. Most entry-level students have a degree in pharmacy or other health-related clinical degree and a master's level graduate degree in population health with a background or interest in pharmaceutical research.
Funding
Research and teaching assistantships and fellowships are available and are awarded on a competitive basis. Assistantship funding includes a competitive stipend and benefits package consisting of tuition and graduate student health insurance.
Please refer to the websites linked below for relevant information for the current Academic Year.
Faculty